Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Announces FDA approval of AirDuo® Digihaler™
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva Pharmaceuticals Europe - Home | Facebook
Teva's DuoResp Spiromax wins silver at MDEA
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | Fierce Pharma
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha
FDA approves Teva's asthma drug Cinqair - Philadelphia Business Journal
Teva Pharmaceuticals Europe - Home | Facebook
Teva Releases AirDuo RespiClick plus Generic for Asthma | RT
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva launches asthma social media campaign - PMLiVE
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Qvar 100 inhaler (Teva UK Ltd) 200 dose - RightBreathe
Teva launches digital asthma and COPD rescue inhaler in US | pharmaphorum
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
